5/20/2023 0 Comments Seashore drugs![]() ![]() ![]() In the United States, researchers at three Harvard University-affiliated hospitals – Massachusetts General Hospital, Dana-Farber Cancer Institute, and Brigham and Women’s Hospital – have been testing the drug on patients with breast, ovarian, and prostate cancer. If received, PharmaMar expects to begin selling the drug in Europe by the end of this year for treatment of soft-tissue sarcomas, cancers affecting blood vessels, muscles, tendons, and other connective tissues including those that hold internal organs in place. Tests on hundreds of patients in Europe have been encouraging enough for the company to apply for approval to market the drug, which they call ET-743. In addition to collecting the squirt, known as Ecteinascidia turbinate, from sea bottoms around the world, a Spanish company, PharmaMar, has established an underwater farm on which the tubelike creatures are being raised. Trials conducted in the United States and Europe show that the compound has promising activity against connective tissue, breast, ovary, and prostate tumors. (Staff photo by Kris Snibbe)Ī powerful cancer drug found in the tissues of sea squirts is being tested on a variety of cancers. The drug is being given to patients with breast, ovarian, prostate, and connective tissue tumors. The complaint said that “King refused to address these concerns on the grounds that he had no control over what happened outside the pharmacy.Professor of Medicine Bruce Chabner is helping to organize tests of a powerful new cancer drug extracted from sea squirts. In another instance, employees reported patients trading drugs in front of the store. In some instances, pharmacist technicians would inform KING of the earlier refusal, but KING would fill the prescription anyway.” “Those customers, however, would return when KING was working and KING would fill them-i.e., the same prescription that another SEASHORE pharmacist refused to fill. “Some SEASHORE pharmacists recognized the red flags associated with controlled-substance prescriptions being presented by individuals and sometimes refused to fill them,” the complaint said. Prosecutors blamed upper management for many of these issues, writing that King allegedly took affirmative steps to bypass concerned employees. “Defendants nevertheless repeatedly dispensed opioids and other controlled substances to doctor-shopping individuals,” the complaint said, “including people who had received controlled-substance prescriptions from ten or more prescribers in the previous five years, and to at least one person who had received controlled-substance prescriptions from twenty-six separate prescribers during the previous five years.”Īccording to the complaint, multiple Seashore patients who acquired opioids “died from prescription drug overdoses within days after Seashore handed them their pills.” They also accuse Waggett and King of ignoring clear signs of “doctor shopping,” saying that pharmacists had access to patients’ prescription histories through North Carolina’s Controlled Substance Reporting System. Prosecutors allege that Waggett and King routinely filled prescriptions written by doctors hundreds of miles away in Florida and dispensed opioids with dosages 2-3 times higher than what the Centers for Disease Control recommends. “Defendants ignored and otherwise failed to take sufficient steps to resolve these red flags before filling the prescriptions.” “From on or about through at least October 2019, Defendants knowingly filled prescriptions for controlled substances that presented significant red flags with respect to their medical legitimacy and/or with respect to whether they were written by a practitioner in the usual course of professional treatment,” read the complaint.
0 Comments
Leave a Reply. |